Deltex Medical Group (LON:DEMG) posted its quarterly earnings results on Monday. The company reported GBX (0.11) ($0.00) EPS for the quarter, Digital Look Earnings reports.
LON DEMG remained flat at $GBX 1.35 ($0.02) during trading hours on Wednesday. The company had a trading volume of 825,976 shares, compared to its average volume of 876,234. The business’s 50-day moving average is GBX 1.43 and its 200-day moving average is GBX 1.43. The company has a quick ratio of 0.89, a current ratio of 1.38 and a debt-to-equity ratio of 60.72. Deltex Medical Group has a one year low of GBX 0.01 ($0.00) and a one year high of GBX 2.90 ($0.04). The stock has a market cap of $7.09 million and a P/E ratio of -21.25.
In other Deltex Medical Group news, insider David Moorhouse purchased 370,000 shares of the stock in a transaction that occurred on Tuesday, September 22nd. The shares were bought at an average cost of GBX 1 ($0.01) per share, with a total value of £3,700 ($4,834.71).
Deltex Medical Group plc manufactures and sells oesophageal doppler monitoring (ODM) systems in the United Kingdom, the United States, Spain, Canada, and internationally. It develops, designs, manufactures, and markets medical devices that generate low frequency ultrasound signal to visualize and measure blood flow in the central circulation.
Receive News & Ratings for Deltex Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Deltex Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.